Announcements Trials
Browse Landscape

Status

Completed 88Terminated 42Recruiting 39Active not recruiting 20Unknown 7Withdrawn 5No longer available 2Suspended 1Not yet recruiting 1Available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Dermatologic 16Gastrointestinal 2CNS 2Thoracic 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Glioblastoma 11Neuroblastoma 6Glioma 6Pheochromocytoma 3Paraganglioma 2Melanoma 2Diffuse Intrinsic Pontine Glioma 2Wilms Tumor 1Thyroid cancer, medullary 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Oligodendroglioma 1Neurofibromatosis 2 1Neuroectodermal Tumors, Primitive 1Neoplasms by Site 1Neoplasms 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Medulloblastoma 1Insulinoma 1Hepatoblastoma 1Gastrointestinal Stromal Tumors 1Dysbiosis 1Disease Progression 1Disease 1Carcinoid Tumor 1Breast Neoplasms 1

Interventions

pembrolizumab 1efineptakin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
No longer available × Melanoma × CNS × Clear all
NCT04289155 2022-03-17

Individual Patient Compassionate Use of GX-I7

Genexine, Inc.

No longer available
CNSDermatologic

Glioblastoma, Glioma, Melanoma

NCT03311542 2018-01-10

Expanded Access for Pembrolizumab (MK-3475)

Center Trials & Treatment

No longer available
CNSDermatologic

Glioblastoma, Glioma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡